PTYLTD
    • Free Reports
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Free Reports

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic

By Topic

Capricorn Metals (ASX: CMM)

Capricorn Metals (ASX: CMM): A High-Margin Gold Engine Scaling for 300koz Growth

Jun 21, 2026
Proactive Equities Team

Capricorn Metals (ASX: CMM) delivers strong cash generation and mine expansion momentum, positioning for 300koz annual production through Karlawinda and Mt Gibson growth. Premium valuation reflects execution strength and long-life margins.

Lotus Resources (ASX: LOT)

Lotus Resources (ASX: LOT) Surges as Selling Pressure Continues to Ease

Jun 23, 2026
Proactive Equities Team

Lotus Resources (ASX: LOT) jumped 14% to $0.66 as investors responded to improving uranium market sentiment and progress at its Kayelekera and Letlhakane projects. The company continues to ramp up production in Malawi while advancing plans to become a potential 5.5 M lb-per-year uranium producer.

Auckland International Airport (ASX: AIA)

Auckland International Airport (ASX: AIA): Infrastructure Momentum Meets Earnings Resilience

Jun 24, 2026
Proactive Equities Team

Auckland Airport (ASX: AIA) delivers steady earnings growth, strong passenger recovery, and disciplined infrastructure execution, positioning New Zealand’s gateway for long‑term value creation.

Mesoblast (ASX: MSB)

Mesoblast (ASX: MSB) Shares Declined Despite Ryoncil Momentum as Investors Lock In Profits

Jun 28, 2026
Proactive Equities Team

Mesoblast (ASX: MSB) is transitioning into a commercial-stage biotech as Ryoncil® sales accelerate and its late-stage pipeline advances. While the share price has eased after a strong rally, growing revenue, improving cash flow, and multiple clinical catalysts continue to support its long-term outlook.

Inoviq (ASX: IIQ)

Inoviq (ASX: IIQ)'s Breakout Reverses Hard: IIQ Slides After EXO-OC Study Reset

Jul 2, 2026
Proactive Equities Team

Inoviq shares plunged after sample-quality issues delayed validation of its EXO-OC ovarian cancer test, despite improved algorithm performance. The sharp reversal has shifted investor focus from growth potential to execution risks, timelines, and confidence in the company’s development strategy.

Manuka Resources (ASX: MKR)

Manuka Resources (ASX: MKR) Pulls Back as the Restart Rally Meets Its First Real Test

Jul 2, 2026
Proactive Equities Team

Manuka Resources is retracing after its May rally as investors await production milestones. With gold processing expected in July and silver production targeted for September, the market is looking for operational results to confirm the company's restart strategy.

...

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1...353637...45
Page 36 of 45